Non-hypertensive tetraPEGylated canine haemoglobin: Correlation between PEGylation, O2 affinity and tissue oxygenation

Biochemical Journal

Volumn 405, Issue 3, 2007, Pages 503-511

  Acharya, Seetharama A ^a   Acharya, Vivek N ^a   Kanika, Nirmala Devi ^a   Tsai, Amy G ^b   Intaglietta, Marcos ^b   Manjula, Belur N ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Blood; Non hypertensive tetraPEGylated canine haemoglobin; O2 affinity; PEGylation; Poly(ethylene glycol) (PEG); Tissue oxygenation

Indexed keywords

BLOOD SUBSTITUTES; HEMOGLOBIN; OXYGENATION; TISSUE;

NON-HYPERTENSIVE TETRAPEGYLATED CANINE HAEMOGLOBIN; PEGYLATION; TETRAPEGYLATED CANINE; TISSUE OXYGENATION;

POLYETHYLENE GLYCOLS;

2,3 DIPHOSPHOGLYCERIC ACID; HEMOGLOBIN; MACROGOL; MALEIMIDE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ERYTHROCYTE; EXPERIMENTAL MODEL; HAMSTER; HEMODILUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; ION EXCHANGE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOTIC PRESSURE; OXYGEN AFFINITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TISSUE OXYGENATION; VISCOSITY;

ANIMALS; CATS; CHICKENS; CRICETINAE; DOGS; HEMOGLOBINS; HUMANS; MALE; MALEIMIDES; MESOCRICETUS; MICE; OXYGEN; POLYETHYLENE GLYCOLS; PROTEIN BINDING; SHEEP;

CRICETINAE;

EID: 34547396502     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20070238     Document Type: Article

References (37)

1. Rohlfs, R. J., Bruner, E., Chiu, A., Gonzales, A., Gonzales, M. L., Magde, M. D., Vandegriff, K. D. and Winslow, R. M. (1998) Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J. Biol. Chem. 273, 12128-12134
2. Winslow, R. M., Gonzales, A., Gonzales, M. L., Magde, M., McCarthy, M., Rohlfs, R. J. and Vandegriff, K. D. (1998) Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J. Appl. Physiol. 85, 993-1003
3. Reiss, J. G. (2001) Oxygen carriers ('blood substitutes') - Raison d'Etre, chemistry, and some physiology. Chem. Rev. 101, 2797-2919
4. Klein, H. G. (2000) The prospects for red-cell substitutes. N. Engl. J. Med. 342, 1666-1668
5. Chang, T. M. S. (1999) Future prospects for artificial blood. Trends Biotechnol. 17, 61-67
6. Winslow, R. M. (1999) New transfusion strategies: red cell substitutes. Annu. Rev. Med. 50, 337-353
7. Winslow, R. M. (1992) Hemoglobin Based Red Cell Substitutes, Johns Hopkins University Press, Baltimore, MD
8. Abuchowski, A. and Nucci, M. L. (1998) The search for blood substitutes. Sci. Am. 278, 72-77
9. Stowell, C. P., Spiess, B. D. and Winslow, R. M. (2001) Progress in the development of RBC substitutes. Transfusion 41, 287-299
10. Yabuki, A., Yamaji, K., Ohki, H. and Iwashita, Y. (1990) Characterization of a pyridoxalated hemoglobin-polyoxyethylene conjugate as a physiologic oxygen carrier Transfusion 30, 516-520
11. Conover, C. D., Linberg, R., Shum, K. L. and Shorr, R. G. (1999) The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models. Artif. Cells Blood Substit. Immobil. Biotechnol. 27, 93-107
12. Abuchowski, A., van Es, T., Palczuk, N. C. and Davis, F. F. (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252, 3578-3581
13. Harris, J. M. and Zalipsky, S. (1997) Poly(ethylene glycol) chemistry and biological applications. Am. Chem. Soc. Symp. Ser. 680, 1-15
14. Harris, J. M. and Chess, R. B. (2003) Effect of PEGylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214-221
15. Bailon, P. and Berthold, W. (1998) Polyethylene glycol-conjugated pharmaceutical proteins. Pharm. Sci. Technol. Today 1, 352-356
16. Pasut, G., Guiotto, A. and Veronese, F. M. (2004) Protein, peptide and non-peptide drug PEGylation for therapeutic application. Expert Opin. Ther. Patents 14, 859-894
17. Roberts, M. J., Bentley, M. D. and Harris, J. M. (2002) Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54, 459-476
18. Tsai, A. G. and Intaglietta, M. (2001) High viscosity plasma expanders: volume restitution fluids for lowering the transfusion trigger. Biorheology 38, 229-237
19. Acharya, A. S., Manjula, B. N. and Smith, P. K. (1996) Hemoglobin crosslinkers, U.S. Patent 5,585,484
20. 6-HbA is non-hypertensive. Artif. Cells Blood Substit. Immobil. Biotechnol. 33, 239-255
21. Manjula, B. N., Tsai, A. G., Intaglietta, M., Tsai, C.-H., Ho, C., Smith, P. K., Perumalsamy, K., Kanika, N. D., Friedman, J. M. and Acharya, A. S. (2005) Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function. Protein J. 42, 133-146
22. Vandegriff, K. D., Malavalli, A., Wooldridge, J., Lohman, J. and Winslow, R. M. (2003) MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43, 509-516
23. Vandegriff, K. D., Rohlfs, R. J. and Winslow, R. M. (1997) Colloid osmotic effects of hemoglobin-based oxygen carriers. In Advances in Blood Substitutes. Industrial Opportunities and Medical Challenges (Winslow, R. M., Vandegriff, K. D. and Intaglietta, M., eds.), pp. 207-227, Birkhauser, Boston
24. 2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamber. Am. J. Physiol. Heart Circ. Physiol. 287, H1609-H1617
25. Manjula, B. N., Tsai, A., Upadhya, R., Perumalsamy, K., Smith, P. K., Malavalli, A., Vandegriff, K. D., Winslow, R. M., Intaglietta, M., Prabhakaran, M. et al. (2003) Site-specific PEGylation of hemoglobin at Cys-93(β): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug. Chem. 14, 464-472
26. Manjula, B. N., Malavalli, A., Smith, P. K., Chan, N. L., Arnone, A., Friedman, J. M. and Acharya, A. S. (2000) Cys-93-ββ-succinimidophenyl polyethylene glycol 2000 hemoglobin A. Intramolecular cross-bridging of hemoglobin outside the central cavity. J. Biol. Chem. 275, 5527-5534
27. Hu, T., Prabhakaran, M., Acharya, S. A. and Manjula, B. N. (2005) Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate. Biochem. J. 392, 555-564
28. Endrich, B., Asaishi, K., Götz, A. and Messmer, K. (1980) Technical report: a new chamber technique for microvascular studies in unanaesthetized hamsters. Res. Exp. Med. 177, 125-134
29. Tsai, A. G., Friesenecker, B., McCarthy, M., Sakai, H. and Intaglietta, M. (1998) Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skin fold model. Am. J. Physiol. 275, H2170-H2180
30. Tsai, A. G. (2001) Influence of cell-free hemoglobin on local tissue perfusion and oxygenation after acute anemia after isovolemic hemodilution. Transfusion 41, 1290-1298
31. Intaglietta, M. and Tompkins, W. R. (1972) On-line microvascular blood cell flow velocity measurement by simplified correlation technique. Microvasc. Res. 4, 217-220
32. Intaglietta, M. and Tompkins, W. R. (1973) Microvascular measurements by video image shearing and splitting. Microvasc. Res. 5, 309-312
33. 2 measurements by phosphorescence decay method. Am. J. Physiol. 265, H1434-H1438
34. Tsai, A. G., Cabrales, P., Manjula, B. N., Acharya, S. A., Winslow, R. M. and Intaglietta, M. (2006) Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood 108, 3603-3610
35. Vandegriff, K. D., Lohman, J. M., Tsai, A. G., Intagliettta, M., Drobin, J., Kjellstrom, B. T. and Winslow, R. M. (2000) Abstract, In VIII International Symposium on Blood Substitutes, San Diego, CA
36. Vandegriff, K. D. (2006) The role of oxygen and hemoglobin diffusion in oxygen transport by cell-free hemoglobins. In Blood Substitutes (Winslow, R. W., ed.), pp, 60-71, Elsevier, London
37. Prabhakaran, M., Manjula, B. N. and Acharya, S. A. (2006) Molecular modeling studies of surface decoration of hemoglobin by maleimide PEG. Artif. Cells Blood Substit. Immobil. Biotechnol. 34, 381-393